Lyell Immunopharma earnings dates
Lyell Immunopharma (LYEL) filed its latest results announcement (Form 8-K, Item 2.02) on Nov 4, 2026. Over the last three years it filed them in mid March, early May, early August and early November. The data provider lists Mar 12, 2027 as the next date; that is not a filing and it can change.
Over the last 9 announcements with prices on file, the stock rose 4 times and fell 5 times from the close before the filing day to the close after it, by 10.7% on average either way. The largest move was +39.3% around Nov 4, 2026.
Results announcements, newest first
| Filed on | Day | Stock move, 2 days | Filing |
|---|---|---|---|
| Mar 12, 2027listed by the data provider, not filed yet | Fri | — | — |
| Nov 4, 2026 | Wed | +39.3% | 8-K |
| Aug 6, 2026 | Thu | +9.4% | 8-K |
| May 6, 2026 | Wed | −2.7% | 8-K |
| Mar 12, 2026 | Thu | −15.5% | 8-K |
| Nov 12, 2025 | Wed | +0.9% |
The move runs from the last close before the filing day to the first close after it, so it covers an announcement made before the open or after the close. Prices are adjusted for splits and dividends; “—” means no prices are stored for those days.
The latest quarter’s figures and insider trades around results: Lyell Immunopharma (LYEL) on OQRO. Every company’s insiders around their results: insider trades around earnings.
Common questions
When does Lyell Immunopharma report earnings?
Lyell Immunopharma (LYEL) filed its latest results announcement (Form 8-K, Item 2.02) on Nov 4, 2026. Over the last three years it filed them in mid March, early May, early August and early November. The data provider lists Mar 12, 2027 as the next date; that is not a filing and it can change.
How has LYEL stock moved after earnings?
Over the last 9 announcements with prices on file, the stock rose 4 times and fell 5 times from the close before the filing day to the close after it, by 10.7% on average either way. The largest move was +39.3% around Nov 4, 2026. Past moves say nothing about the next one.
How many results announcements has Lyell Immunopharma filed?
22 since Aug 12, 2021 in the SEC's EDGAR records, about 4 a year lately. A company can file more than four a year when it also releases preliminary figures.
Where these figures come from
Dates are the filing dates of the company’s Form 8-K reports with Item 2.02 (“Results of Operations and Financial Condition”) in the SEC’s EDGAR records. Two such filings within a week count as one announcement. The list is read again every day.
OQRO does not predict the next date. When the data provider lists one, it appears at the top, marked as not filed. This page describes the past and is not investment advice. No language model wrote it.
